Rudy Birsen

1.4k total citations
32 papers, 454 citations indexed

About

Rudy Birsen is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Rudy Birsen has authored 32 papers receiving a total of 454 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 12 papers in Hematology and 11 papers in Oncology. Recurrent topics in Rudy Birsen's work include Acute Myeloid Leukemia Research (7 papers), Lymphoma Diagnosis and Treatment (7 papers) and Ferroptosis and cancer prognosis (4 papers). Rudy Birsen is often cited by papers focused on Acute Myeloid Leukemia Research (7 papers), Lymphoma Diagnosis and Treatment (7 papers) and Ferroptosis and cancer prognosis (4 papers). Rudy Birsen collaborates with scholars based in France, Switzerland and United States. Rudy Birsen's co-authors include Didier Bouscary, Nicolas Chapuis, Éric Grignano, Jérôme Tamburini, Olivier Kosmider, Michaëla Fontenay, Patrick Mayeux, Justine Decroocq, Clément Larrue and Jean Emmanuel Sarry and has published in prestigious journals such as Blood, Science Translational Medicine and British Journal of Haematology.

In The Last Decade

Rudy Birsen

26 papers receiving 452 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rudy Birsen France 11 247 156 133 123 78 32 454
Rika Kasajima Japan 10 129 0.5× 90 0.6× 71 0.5× 126 1.0× 26 0.3× 37 350
Cunte Chen China 12 199 0.8× 95 0.6× 95 0.7× 138 1.1× 39 0.5× 48 478
Chaitanya Iragavarapu United States 8 213 0.9× 71 0.5× 62 0.5× 33 0.3× 66 0.8× 15 392
Jessica Boklan United States 12 215 0.9× 55 0.4× 134 1.0× 41 0.3× 62 0.8× 30 467
Maoxiang Qian China 11 315 1.3× 77 0.5× 189 1.4× 93 0.8× 18 0.2× 43 516
Jérôme Alexandre France 3 296 1.2× 174 1.1× 30 0.2× 78 0.6× 47 0.6× 4 445
O. I. Olopade United States 9 209 0.8× 52 0.3× 44 0.3× 136 1.1× 66 0.8× 14 491
Lola Luo United States 8 128 0.5× 69 0.4× 164 1.2× 62 0.5× 80 1.0× 8 403
Jana L. Dawson United States 11 658 2.7× 56 0.4× 230 1.7× 56 0.5× 36 0.5× 26 778
Qirong Geng China 12 172 0.7× 158 1.0× 32 0.2× 117 1.0× 15 0.2× 27 469

Countries citing papers authored by Rudy Birsen

Since Specialization
Citations

This map shows the geographic impact of Rudy Birsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rudy Birsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rudy Birsen more than expected).

Fields of papers citing papers by Rudy Birsen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rudy Birsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rudy Birsen. The network helps show where Rudy Birsen may publish in the future.

Co-authorship network of co-authors of Rudy Birsen

This figure shows the co-authorship network connecting the top 25 collaborators of Rudy Birsen. A scholar is included among the top collaborators of Rudy Birsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rudy Birsen. Rudy Birsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Loap, Pierre, et al.. (2025). Exposure to the immune system during bridging radiotherapy for Car-T cells. Cancer/Radiothérapie. 29(2). 104595–104595.
2.
Tazi, Asmaa, Caroline Charre, A. Paugam, et al.. (2025). Prevention and management of infectious diseases in pregnant women with haematological malignancies. The Lancet Haematology. 12(10). e836–e849.
3.
Vigneron, Clara, et al.. (2024). Severe bleeding events among critically ill patients with haematological malignancies. Annals of Intensive Care. 14(1). 155–155. 4 indexed citations
4.
Decroocq, Justine, Laurent Chouchana, Vassilis Tsatsaris, et al.. (2024). Maternal and obstetric outcomes in women with pregnancy-associated haematological malignancies: an observational nationwide cohort study. The Lancet Haematology. 11(11). e850–e861. 2 indexed citations
5.
Pagès, Arnaud, Rudy Birsen, Adrien Contejean, et al.. (2024). Venetoclax–proteasome inhibitor–dexamethasone for unfit patients with blastic plasmacytoid dendritic cell neoplasm. Blood Advances. 9(4). 793–796. 2 indexed citations
6.
Loap, Pierre, Ludovic De Marzi, Justine Decroocq, et al.. (2024). Proton Therapy Reduces the Effective Dose to Immune Cells in Mediastinal Hodgkin Lymphoma Patients. International Journal of Particle Therapy. 13. 100110–100110. 2 indexed citations
7.
Loap, Pierre, et al.. (2024). Tolerance of radiotherapy with concomitant glofitamab in diffuse large B cell lymphoma: a case report. Strahlentherapie und Onkologie. 200(11). 983–985. 1 indexed citations
8.
9.
10.
Birsen, Rudy, et al.. (2023). Acute lead poisoning mimicking posterior reversible encephalopathy. BMJ Case Reports. 16(6). e254199–e254199.
11.
Prata, Pedro Henrique, Jacques‐Emmanuel Galimard, Flore Sicre de Fontbrune, et al.. (2023). Rare germline complement factor H variants in patients with paroxysmal nocturnal hemoglobinuria. Blood. 141(15). 1812–1816. 7 indexed citations
12.
Larrue, Clément, Sarah Mouche, Shan Lin, et al.. (2023). Mitochondrial fusion is a therapeutic vulnerability of acute myeloid leukemia. Leukemia. 37(4). 765–775. 31 indexed citations
13.
Zerbit, Jérémie, Antoine Meyer, Justine Decroocq, et al.. (2022). Patients with Hematological Malignancies Treated with T-Cell or B-Cell Immunotherapy Remain at High Risk of Severe Forms of COVID-19 in the Omicron Era. Viruses. 14(11). 2377–2377. 15 indexed citations
14.
Birsen, Rudy, et al.. (2022). When refeeding is not enough: severe and prolonged pancytopenia in an adolescent with anorexia nervosa. Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity. 27(8). 3797–3801. 1 indexed citations
15.
Moiraghi, Alessandro, Rudy Birsen, Angela Rita Elia, et al.. (2022). Accuracy and safety of 101 consecutives neurosurgical procedures for newly diagnosed central nervous system lymphomas: a single-institution experience. Journal of Neuro-Oncology. 159(2). 347–358. 3 indexed citations
16.
Birsen, Rudy, Clément Larrue, Justine Decroocq, et al.. (2021). APR-246 induces early cell death by ferroptosis in acute myeloid leukemia. Haematologica. 107(2). 403–416. 131 indexed citations
17.
Grignano, Éric, Rudy Birsen, Nicolas Chapuis, & Didier Bouscary. (2020). From Iron Chelation to Overload as a Therapeutic Strategy to Induce Ferroptosis in Leukemic Cells. Frontiers in Oncology. 10. 586530–586530. 40 indexed citations
18.
Meunier, Godelieve, Rudy Birsen, Olivier Kosmider, et al.. (2020). Antileukemic activity of the VPS34-IN1 inhibitor in acute myeloid leukemia. Oncogenesis. 9(10). 94–94. 31 indexed citations
19.
Chapuis, Nicolas, Laury Poulain, Rudy Birsen, Jérôme Tamburini, & Didier Bouscary. (2019). Rationale for Targeting Deregulated Metabolic Pathways as a Therapeutic Strategy in Acute Myeloid Leukemia. Frontiers in Oncology. 9. 405–405. 22 indexed citations
20.
Bories, Phuong-Nhi, Samir Nakib, Luc Cynober, et al.. (2018). Establishing assay-specific 97.5th percentile upper reference limit for serum D-2-hydroxyglutarate for the management of patients with acute myeloid leukemia. Clinical Chemistry and Laboratory Medicine (CCLM). 57(4). e57–e59. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rika Kasajima Breakdown of academic impact, for papers by Cunte Chen Breakdown of academic impact, for papers by Chaitanya Iragavarapu Breakdown of academic impact, for papers by Jessica Boklan Breakdown of academic impact, for papers by Maoxiang Qian Breakdown of academic impact, for papers by Jérôme Alexandre Breakdown of academic impact, for papers by O. I. Olopade Breakdown of academic impact, for papers by Lola Luo Breakdown of academic impact, for papers by Jana L. Dawson Breakdown of academic impact, for papers by Qirong Geng
Rankless by CCL
2026